{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:35:15Z","timestamp":1786988115137,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.ejpb.2006.07.001","type":"journal-article","created":{"date-parts":[[2006,7,9]],"date-time":"2006-07-09T07:06:52Z","timestamp":1152428812000},"page":"78-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations"],"prefix":"10.1016","volume":"65","author":[{"given":"Therese","family":"Riis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Bauer-Brandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Kranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2006.07.001_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0169-409X(01)00179-X","article-title":"Predicting the impact of physiological and biochemical processes on oral drug bioavailability","volume":"50","author":"Agoram","year":"2001","journal-title":"Adv. Drug Deliver. Rev."},{"key":"10.1016\/j.ejpb.2006.07.001_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0168-3659(03)00075-0","article-title":"Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion","volume":"89","author":"De Brabander","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2006.07.001_bib3","series-title":"Tablets and Compaction in Pharmaceutics","author":"Alderborn","year":"2002"},{"key":"10.1016\/j.ejpb.2006.07.001_bib4","unstructured":"BASF AG, Technical information for Kollidon SR, Ludwigshafen, Germany, 1999."},{"key":"10.1016\/j.ejpb.2006.07.001_bib5","first-page":"624","article-title":"Evaluation of the new polyvinylacetate\/povidone excipient for matrix sustained release dosage forms","volume":"63","author":"Draganoiu","year":"2001","journal-title":"Pharm. Ind."},{"key":"10.1016\/j.ejpb.2006.07.001_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpharm.2005.04.026","article-title":"Development of a multi particulate extended release formulation for ZK 811 752, a weakly basic drug","volume":"299","author":"Kranz","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2006.07.001_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejps.2005.04.018","article-title":"Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug","volume":"26","author":"Kranz","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2006.07.001_bib8","series-title":"Die Tablette","author":"Ritschel","year":"2002"},{"key":"10.1016\/j.ejpb.2006.07.001_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jconrel.2004.12.015","article-title":"Influence of micro-environmental pH on the gel layer behavior and release of a basic drug from various hydrophilic matrices","volume":"103","author":"Varma","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2006.07.001_bib10","unstructured":"K. Kolter, R. Bodmeier, A. Dashevsky, Kombination von Polyvinylacetat mit wasserunl\u00f6slichen, s\u00e4ureunl\u00f6slichen oder alkaliunl\u00f6slichen Polymeren zur Herstellung von Film\u00fcberz\u00fcgen mit sehr kontrollierter Freisetzung und hoher Stabilit\u00e4t, Deutsche Offenlegungsschrift DE 102 11 289 A 1, 2002."},{"key":"10.1016\/j.ejpb.2006.07.001_bib11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejpb.2004.03.013","article-title":"pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat\u00ae SR 30 D and the enteric polymer dispersion Kollicoat\u00ae MAE 30 DP","volume":"58","author":"Dashevsky","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2006.07.001_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0378-5173(96)04834-X","article-title":"An organic acid-induced sigmoidal release system for oral controlled release preparations. 3. Elucidation of the anomalous drug release behavior through osmotic pumping mechanism","volume":"148","author":"Narisawa","year":"1997","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2006.07.001_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-5173(00)00406-3","article-title":"Influence of admixed citric acid in the release profile of pelanserin hydrochloride from HPMC matrix tablets","volume":"201","author":"Espinoza","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2006.07.001_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-3659(00)00200-5","article-title":"pH-independent release of a weakly basic drug from water-insoluble and -soluble matrix tablets","volume":"67","author":"Streubel","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2006.07.001_bib15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0378-5173(89)90126-9","article-title":"Microenviromental pH control of drug dissolution","volume":"50","author":"Doherty","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2006.07.001_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-5173(02)00622-1","article-title":"Design of pH-independent controlled release matrix tablets for acidic drugs","volume":"252","author":"Rao","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2006.07.001_bib17","first-page":"531","article-title":"Complexation and cyclodextrins","volume":"vol. 1","author":"Mosher","year":"2002"},{"key":"10.1016\/j.ejpb.2006.07.001_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0378-5173(03)00366-1","article-title":"The effect of \u03b2-cyclodextrins on the permeation of diclofenac from supersaturated solutions","volume":"263","author":"Dias","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2006.07.001_bib19","unstructured":"Merck Index, vol. XII. Whitehouse Station, NJ, 1996."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641106001615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641106001615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:26:45Z","timestamp":1760545605000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641106001615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0939641106001615"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2006.07.001","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"pH-independent drug release of an extremely poorly soluble weakly acidic drug from multiparticulate extended release formulations","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2006.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}